Empyema
What is it
The
pleural space is actually a potential space created by the visceral
and parietal pleura. Normally, it contains a little amount of fluid
which facilitates movement of the lung with the diaphragm and chest
wall. When there is some plural fluid collected abnormally in this
space, we call it thoracic effusion. A thoracic effusion provides a
rich culture medium in which white blood cell defenses can be
impaired and an empyema may flourish. Empyema is the presence of
gross pus in the pleural cavity, it consists of an effusion
containing polymorphonuclear leukocytes and fibrin.
Development
By
convention, the formation of an empyema can be divided into three
phases: exudative, fibrinopurulent and organizing. During the first
or exudative phase, pus accumulates. This is followed by fibrin
deposition and loculation of pleural fluid known as the
fibrinopurulent phase. The last phase,the organizing phase, is
characterized by fibroblast proliferation; at this time there is the
potential for lung entrapment by scarring.
Symptom
Pleural
effusions are most common in patients with pneumonia. However,
empyema is a rare complication of pneumonia. Most patients with
empyema will have persistent symptoms despite antibiotic therapy for
pneumonia. Symptoms include fever, cough, dyspnea, and pleuritic
chest pain.
Diagnosis
A
chest radiograph will demonstrate a parapneumonic effusion; a sample
of the fluid should be obtained by thoracentesis. The diagnosis of
empyema is made when gross inspection of the pleural fluid reveals
pus. A positive gram stain by microscopic analysis also clinches the
diagnosis.
Pleural
fluid cultures are often negative in patients with empyema and may
be negative secondary to antibiotic therapy or inability to grow the
organism. Ultrasound and CT scan determine if an effusion is free
flowing or walled off, loculated, or abscess-like.
How to treat
As
we know, the management of empyema involves three core principles:
-
Usage
of appropriate antibiotics
-
Complete
evacuation of suppurative pleural fluid
-
Preservation
or restoration of lung expansion.
With
needle thoracentesis or large closed-tube thoracostomy, and
antibiotics, thin fluid in exudative stage can occasionally be
completely evacuated and the disease controlled. When it comes into
fibrinopurulent stage, viscosity of the pleural fluid is increasing,
coagulation factors are activated, and fibroblast activity begins
coating the pleural membrane with an adhesive meshwork. So the
drainage alone maybe not effective while it is often blocked by
fibrosis or necrosis tissue.
We
only can clear these fragments and pus completely thoracoscopically
with good visualization. Thorascopic pleural evacuation and/or
decortication earlier in the clinical course (presumably during the
fibrinopurulent stage) can reduce hospital stay due to the
infectious process and the morbidity.
The VATS procedure
After one-lung
ventilation established with aid of a double-lumen endotracheal
tube, the patient is placed in a lateral decubitus position. Placing
the patient over a large axillary role widens the contralateral
intercostals spaces and facilitates trocar insertion. Based on
preoperative imaging studies, two or three small suitable incisions
are made in the lateral chest wall for port placement. 10 mm
instruments may be utilized for adult patient. The pleural space is
inspected and coagulum removed completely. Interlobar collections
should also be sought and removed. Adherent peel is carefully
removed from visceral and parietal pleural surfaces.
Once the coagulum is completely evacuated and the
peel removed, the lung is inflated. It is essential that the lung
occupy the complete hemithorax upon inflation to minimize pleural
space problems such as persistent atelectesis and recurrent empyema.
The pleural space is irrigated with clean solution and a chest tube
is placed via the lowest port site for thoracoscopy. And another
tube will be inserted via the upper port site, usually in anterior
chest wall for continual postoperative irrigation.
|